Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.

Recent & Breaking News (GREY:DGCRF)

DiagnoCure to host Q2 2013 earnings conference call and webcast

PR Newswire May 28, 2013

DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO annual meeting

Canada NewsWire May 16, 2013

DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO annual meeting

PR Newswire May 16, 2013

DiagnoCure Directors Re-Elected by Shareholders at Annual and Special Meeting of Shareholders

PR Newswire April 29, 2013

DiagnoCure Directors Re-Elected by Shareholders at Annual and Special Meeting of Shareholders

Canada NewsWire April 29, 2013

DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders

PR Newswire April 29, 2013

DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders

Canada NewsWire April 29, 2013

DiagnoCure Urges Shareholders to Vote Today to Protect Your Investment from Dissident Minority Shareholders - What is the Dissidents' Plan? Disruption to Newly-Formed and Highly-Qualified Board may Jeopardize Company's Future

Canada NewsWire April 22, 2013

Nominations pursuant to advance notice policy

Canada NewsWire April 15, 2013

DiagnoCure's adoption of an advance notice policy

Canada NewsWire April 9, 2013

New Research on PCA3 Presented at the 2013 European Association of Urology (EAU) Congress

Canada NewsWire March 21, 2013

DiagnoCure announces first quarter 2013 results

Canada NewsWire March 11, 2013

DiagnoCure to host Q1 2013 earnings conference call and webcast

Canada NewsWire February 28, 2013

DiagnoCure announces fourth quarter 2012 and year-end results

Canada NewsWire January 11, 2013

DiagnoCure to host Q4 2012 and full year earnings conference call and webcast

Canada NewsWire January 7, 2013

Canadian small/micro-cap weekend roundup

Stockhouse Editorial February 18, 2012

Junior miner surges on gold assays

Sean Mason February 15, 2012

Junior miner powers higher on coal sales

Sean Mason June 15, 2011